Society for Translational Oncology navigateright Episode
Autologous T cells that have been genetically redirected with chimeric antigen receptors (CARs) specific to the CD19 antigen have achieved remarkable success in inducing rapid and sometimes complete eradication of B cell leukemias and lymphomas. New forms of CARs, including those targeting new surface molecules alone and in combination with additional functionalities, are under intense investigation. We will discuss some of our innovations in cell therapies, including strategies designed to overcome tumor heterogeneity and the tumor microenvironment.
Video Overview: https://youtu.be/lCbIH0Ace-g
Marcela Maus, MD, PhD
MGH Cancer Center
STO gratefully acknowledges educational grants in partial support of this activity from:
Novartis Pharmaceuticals Corp.